New CGM device aims to improve blood sugar control for diabetes patients
NCT ID NCT06704672
First seen Oct 01, 2025 · Last updated May 20, 2026 · Updated 34 times
Summary
This study tests whether a continuous glucose monitor (CGM) called Accu-Chek SmartGuide helps adults with type 1 or type 2 diabetes spend more time with blood sugar in the target range (70-180 mg/dL) compared to standard fingerstick testing. About 270 adults who use daily insulin injections will use the CGM for several months. The goal is to see if the device leads to better daily blood sugar control without increasing low blood sugar episodes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES MELLITUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Bakırköy Sadi Konuk Training and Research Hospital
RECRUITINGBakirkoy Istanbul, 34147, Turkey (Türkiye)
-
Baskent University Department of Endocrinology and Metabolism
RECRUITINGAdana, 01240, Turkey (Türkiye)
-
BioResearch Group Sp. z o. o.
RECRUITINGNadarzyn, 05-830, Poland
-
Centrum Badań Klinicznych PI-House sp. z o.o.
RECRUITINGGdansk, 80-546, Poland
-
Cerrahpasa Medical School Department of Endocrinology
RECRUITINGIstanbul, 34303, Turkey (Türkiye)
-
Clinic of Internal Diseases, Endocrinology and Diabetology State Medical Institute MSWiA
RECRUITINGWarsaw, 02-507, Poland
-
Diabetes Technology Center, Jagiellonian University Medical College
RECRUITINGKrakow, 31-501, Poland
-
ETG Warszawa
RECRUITINGWarsaw, 02-677, Poland
-
Göztepe Prof. Dr. Süleyman Yalçın City Hospital
RECRUITINGIstanbul, 34722, Turkey (Türkiye)
-
Institute of Rural Health
RECRUITINGLublin, 20-090, Poland
-
KO-MED Centra Kliniczne Lublin II
RECRUITINGLublin, 30-362, Poland
-
Koç University Hospital
RECRUITINGIstanbul, 34010, Turkey (Türkiye)
-
Medeniyet University Hospital - İST (Prof. Dr. Süleyman Yalçın City Hospital, Internal Diseases)
RECRUITINGIstanbul, 34722, Turkey (Türkiye)
-
Medical Faculty of Istanbul University, Division of Endocrinology and Metabolism
RECRUITINGIstanbul, 34303, Turkey (Türkiye)
-
NZOZ Neuromed
RECRUITINGKraśnik, 23-204, Poland
-
NZOZ Neuromed
RECRUITINGLublin, 20-064, Poland
-
Nbr Polska
RECRUITINGWarsaw, 00-710, Poland
-
Ümraniye Training and Research Hospital
RECRUITINGÜmraniye / İstanbul, 34764, Turkey (Türkiye)
Conditions
Explore the condition pages connected to this study.